HCPCS code J9049 — Inj, bortezomib, hospira.
Status: Active.
Effective Jan 1, 2023.
Source: CMS HCPCS Level II.
J9049
ActiveInj, bortezomib, hospira
Injection, bortezomib (hospira), not therapeutically equivalent to j9041, 0.1 mg
Category:
Drugs
Section:
J-codes: Drugs Administered Other Than Oral Method
Effective:
Jan 1, 2023
Code type:
alphanumeric
OPPS Status:
N
— Items / services packaged into APC rates
MUE — Medically Unlikely Edits
Maximum units of J9049 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.
| Service Type | Max Units / Day |
|---|---|
| DME Supplier | 35 |
| Outpatient Hospital | 35 |
| Practitioner Services | 35 |
Source: CMS Medicare NCCI Medically Unlikely Edits
NDC Crosswalk
National Drug Codes (NDCs) mapped to this HCPCS code.
| NDC | Drug Name |
|---|---|
| 00409-1703-01 | Bortezomib |
| 00409-1704-01 | Bortezomib |
Change History
Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.
-
New Code 2023-Q1Inj, bortezomib, hospira